These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2164064)

  • 1. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination.
    Carney DF; Lang TJ; Shin ML
    J Immunol; 1990 Jul; 145(2):623-9. PubMed ID: 2164064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    Carney DF; Hammer CH; Shin ML
    J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH; Carney DF; Hammer CH; Shin ML
    J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF; Koski CL; Shin ML
    J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid mobilization and phosphoinositide turnover by the terminal complement complex, C5b-9, in rat oligodendrocyte x C6 glioma cell hybrids.
    Shirazi Y; McMorris FA; Shin ML
    J Immunol; 1989 Jun; 142(12):4385-91. PubMed ID: 2542410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of diacylglycerol and ceramide during homologous complement activation.
    Niculescu F; Rus H; Shin S; Lang T; Shin ML
    J Immunol; 1993 Jan; 150(1):214-24. PubMed ID: 8417124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublytic complement attack induces cell cycle in oligodendrocytes.
    Rus HG; Niculescu F; Shin ML
    J Immunol; 1996 Jun; 156(12):4892-900. PubMed ID: 8648139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane signaling by complement C5b-9, the membrane attack complex.
    Nicholson-Weller A; Halperin JA
    Immunol Res; 1993; 12(3):244-57. PubMed ID: 8288945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9.
    Papadimitriou JC; Ramm LE; Drachenberg CB; Trump BF; Shin ML
    J Immunol; 1991 Jul; 147(1):212-7. PubMed ID: 1904901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.
    Reiter Y; Ciobotariu A; Jones J; Morgan BP; Fishelson Z
    J Immunol; 1995 Aug; 155(4):2203-10. PubMed ID: 7636268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes.
    Shirazi Y; Rus HG; Macklin WB; Shin ML
    J Immunol; 1993 May; 150(10):4581-90. PubMed ID: 7683324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal complement complex and endothelial cells.
    Suttorp N; Bhakdi S
    Z Kardiol; 1989; 78 Suppl 6():140-2. PubMed ID: 2515670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9.
    Chen Y; Zhang J; Guo G; Ruan Z; Jiang M; Wu S; Guo S; Fei L; Tang Y; Yang C; Jia Z; Wu Y
    Mol Immunol; 2009 Jan; 46(3):375-83. PubMed ID: 19081139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
    Debernardi MA; Munshi R; Brooker G
    Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP; Imagawa DK; Dankert JR; Ramm LE
    J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
    Cybulsky AV; Quigg RJ; Salant DJ
    J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.